Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16001 | 678 | 42.6 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
546 | 2 | CHEMOKINES//CXCR4//CHEMOKINE RECEPTOR | 14674 |
16001 | 1 | FRACTALKINE//CX3CR1//CX3CL1 | 678 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FRACTALKINE | authKW | 5531721 | 28% | 64% | 191 |
2 | CX3CR1 | authKW | 2457430 | 17% | 48% | 113 |
3 | CX3CL1 | authKW | 2122895 | 10% | 68% | 69 |
4 | FRACTALKINE RECEPTOR | authKW | 300234 | 1% | 67% | 10 |
5 | FRACTALKINE CX3CL1 | authKW | 240187 | 1% | 67% | 8 |
6 | CELLULAR GENE THER IES HFM518 | address | 135108 | 0% | 100% | 3 |
7 | CX3CL1 CX3CR1 AXIS | authKW | 135108 | 0% | 100% | 3 |
8 | FRACTALKINE CX3CR1 | authKW | 135108 | 0% | 100% | 3 |
9 | PHARMACOL TOXICOL RWTH | address | 90072 | 0% | 100% | 2 |
10 | CHEMOKINES | authKW | 85931 | 20% | 1% | 137 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 1623 | 24% | 0% | 166 |
2 | Neurosciences | 553 | 19% | 0% | 126 |
3 | Peripheral Vascular Diseases | 473 | 8% | 0% | 57 |
4 | Hematology | 431 | 8% | 0% | 57 |
5 | Medicine, Research & Experimental | 220 | 8% | 0% | 53 |
6 | Cell Biology | 205 | 11% | 0% | 73 |
7 | Rheumatology | 197 | 3% | 0% | 23 |
8 | Oncology | 86 | 8% | 0% | 54 |
9 | Biochemistry & Molecular Biology | 66 | 13% | 0% | 87 |
10 | Urology & Nephrology | 55 | 3% | 0% | 23 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELLULAR GENE THER IES HFM518 | 135108 | 0% | 100% | 3 |
2 | PHARMACOL TOXICOL RWTH | 90072 | 0% | 100% | 2 |
3 | U543 | 66160 | 2% | 11% | 13 |
4 | ECCELLENZA BEMM | 48944 | 1% | 22% | 5 |
5 | ANIM MODELS NEURODEGENERAT DIS | 45036 | 0% | 100% | 1 |
6 | ARTHRITIS CLIN IMMUNOL PROGRAMS | 45036 | 0% | 100% | 1 |
7 | ASSISTANCE PUBL HOP PARISU543 | 45036 | 0% | 100% | 1 |
8 | AZIENDA UNIV OSPED SAN GIOVANNI BATTISTA | 45036 | 0% | 100% | 1 |
9 | CARDIOVASCULAR PULM DISSECT INTERVENT CARD | 45036 | 0% | 100% | 1 |
10 | CARE SCI SOCIETY KAROLINSKA | 45036 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROINFLAMMATION | 3237 | 2% | 1% | 11 |
2 | FRONTIERS IN CELLULAR NEUROSCIENCE | 2252 | 1% | 1% | 9 |
3 | JOURNAL OF NEUROIMMUNOLOGY | 1909 | 3% | 0% | 17 |
4 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 1520 | 2% | 0% | 16 |
5 | JOURNAL OF IMMUNOLOGY | 765 | 5% | 0% | 31 |
6 | CYTOKINE | 639 | 1% | 0% | 8 |
7 | ANGLIA-ZEITSCHRIFT FUR ENGLISCHE PHILOLOGIE | 473 | 0% | 1% | 2 |
8 | ARTHRITIS AND RHEUMATISM | 422 | 1% | 0% | 10 |
9 | NEPHRON EXPERIMENTAL NEPHROLOGY | 355 | 0% | 0% | 2 |
10 | JOURNAL OF LEUKOCYTE BIOLOGY | 305 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FRACTALKINE | 5531721 | 28% | 64% | 191 | Search FRACTALKINE | Search FRACTALKINE |
2 | CX3CR1 | 2457430 | 17% | 48% | 113 | Search CX3CR1 | Search CX3CR1 |
3 | CX3CL1 | 2122895 | 10% | 68% | 69 | Search CX3CL1 | Search CX3CL1 |
4 | FRACTALKINE RECEPTOR | 300234 | 1% | 67% | 10 | Search FRACTALKINE+RECEPTOR | Search FRACTALKINE+RECEPTOR |
5 | FRACTALKINE CX3CL1 | 240187 | 1% | 67% | 8 | Search FRACTALKINE+CX3CL1 | Search FRACTALKINE+CX3CL1 |
6 | CX3CL1 CX3CR1 AXIS | 135108 | 0% | 100% | 3 | Search CX3CL1+CX3CR1+AXIS | Search CX3CL1+CX3CR1+AXIS |
7 | FRACTALKINE CX3CR1 | 135108 | 0% | 100% | 3 | Search FRACTALKINE+CX3CR1 | Search FRACTALKINE+CX3CR1 |
8 | CHEMOKINES | 85931 | 20% | 1% | 137 | Search CHEMOKINES | Search CHEMOKINES |
9 | CHEMOKINE CX3CL1 | 67551 | 0% | 50% | 3 | Search CHEMOKINE+CX3CL1 | Search CHEMOKINE+CX3CL1 |
10 | ACTION SPECIFICITY | 45036 | 0% | 100% | 1 | Search ACTION+SPECIFICITY | Search ACTION+SPECIFICITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LIU, WM , JIANG, LB , BIAN, C , LIANG, Y , XING, R , YISHAKEA, M , DONG, J , (2016) ROLE OF CX3CL1 IN DISEASES.ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. VOL. 64. ISSUE 5. P. 371 -383 | 89 | 72% | 0 |
2 | CORCIONE, A , FERRETTI, E , PISTOIA, V , (2014) ROLE OF FRACTALKINE/CX3CL1 AND ITS RECEPTOR IN THE PATHOGENESIS OF INFLAMMATORY AND MALIGNANT DISEASES WITH EMPHASIS ON B CELL MALIGNANCIES.MEDIATORS OF INFLAMMATION. VOL. . ISSUE . P. - | 63 | 70% | 12 |
3 | LIU, H , JIANG, DQ , (2011) FRACTALKINE/CX3CR1 AND ATHEROSCLEROSIS.CLINICA CHIMICA ACTA. VOL. 412. ISSUE 13-14. P. 1180-1186 | 55 | 85% | 26 |
4 | LAURO, C , CATALANO, M , TRETTEL, F , LIMATOLA, C , (2015) FRACTALKINE IN THE NERVOUS SYSTEM: NEUROPROTECTIVE OR NEUROTOXIC MOLECULE?.NEUROIMMUNOMODULATION IN HEALTH AND DISEASE. VOL. 1351. ISSUE . P. 141 -148 | 53 | 74% | 9 |
5 | D'HAESE, JG , DEMIR, IE , FRIESS, H , CEYHAN, GO , (2010) FRACTALKINE/CX3CR1: WHY A SINGLE CHEMOKINE-RECEPTOR DUO BEARS A MAJOR AND UNIQUE THERAPEUTIC POTENTIAL.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 14. ISSUE 2. P. 207-219 | 56 | 60% | 52 |
6 | KOZIOLEK, MJ , VASKO, R , BRAMLAGE, C , MULLER, GA , STRUTZ, F , (2009) THE CX3C-CHEMOKINE FRACTALKINE IN KIDNEY DISEASES.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 10. P. 1215-1228 | 55 | 67% | 12 |
7 | SUNNEMARK, D , ELTAYEB, S , NILSSON, M , WALLSTROM, E , LASSMANN, H , OLSSON, T , BERG, AL , ERICSSON-DAHLSTRAND, A , (2005) CX(3)CL1 (FRACTALKINE) AND CX(3)CR1 EXPRESSION IN MYELIN OLIGODENDROCYTE GLYCOPROTEIN-INDUCED EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS: KINETICS AND CELLULAR ORIGIN.JOURNAL OF NEUROINFLAMMATION. VOL. 2. ISSUE . P. - | 48 | 80% | 62 |
8 | LUDWIG, A , WEBER, C , (2007) TRANSMEMBRANE CHEMOKINES: VERSATILE 'SPECIAL AGENTS' IN VASCULAR INFLAMMATION.THROMBOSIS AND HAEMOSTASIS. VOL. 97. ISSUE 5. P. 694 -703 | 63 | 53% | 78 |
9 | CLARK, AK , STANILAND, AA , MALCANGIO, M , (2011) FRACTALKINE/CX3CR1 SIGNALLING IN CHRONIC PAIN AND INFLAMMATION.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 12. ISSUE 10. P. 1707-1714 | 46 | 61% | 15 |
10 | FLIERL, U , BAUERSACHS, J , SCHAFER, A , (2015) MODULATION OF PLATELET AND MONOCYTE FUNCTION BY THE CHEMOKINE FRACTALKINE (CX(3)CL1) IN CARDIOVASCULAR DISEASE.EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. VOL. 45. ISSUE 6. P. 624 -633 | 42 | 59% | 2 |
Classes with closest relation at Level 1 |